Literature DB >> 14556002

Hepatocyte growth factor and its receptor are required for malaria infection.

Margarida Carrolo1, Silvia Giordano, Laura Cabrita-Santos, Simona Corso, Ana M Vigário, Susana Silva, Patricia Leirião, Daniel Carapau, Rosario Armas-Portela, Paolo M Comoglio, Ana Rodriguez, Maria M Mota.   

Abstract

Plasmodium, the causative agent of malaria, must first infect hepatocytes to initiate a mammalian infection. Sporozoites migrate through several hepatocytes, by breaching their plasma membranes, before infection is finally established in one of them. Here we show that wounding of hepatocytes by sporozoite migration induces the secretion of hepatocyte growth factor (HGF), which renders hepatocytes susceptible to infection. Infection depends on activation of the HGF receptor, MET, by secreted HGF. The malaria parasite exploits MET not as a primary binding site, but as a mediator of signals that make the host cell susceptible to infection. HGF/MET signaling induces rearrangements of the host-cell actin cytoskeleton that are required for the early development of the parasites within hepatocytes. Our findings identify HGF and MET as potential targets for new approaches to malaria prevention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556002     DOI: 10.1038/nm947

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  47 in total

Review 1.  A long and winding road: the Plasmodium sporozoite's journey in the mammalian host.

Authors:  Photini Sinnis; Alida Coppi
Journal:  Parasitol Int       Date:  2007-04-24       Impact factor: 2.230

Review 2.  Live and let die: manipulation of host hepatocytes by exoerythrocytic Plasmodium parasites.

Authors:  Angelika Sturm; Volker Heussler
Journal:  Med Microbiol Immunol       Date:  2007-04-05       Impact factor: 3.402

Review 3.  Looking under the skin: the first steps in malarial infection and immunity.

Authors:  Robert Ménard; Joana Tavares; Ian Cockburn; Miles Markus; Fidel Zavala; Rogerio Amino
Journal:  Nat Rev Microbiol       Date:  2013-10       Impact factor: 60.633

4.  The crucial role of hepatocyte growth factor receptor during liver-stage infection is not conserved among Plasmodium species.

Authors:  Alexis Kaushansky; Stefan H I Kappe
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

Review 5.  Of men in mice: the success and promise of humanized mouse models for human malaria parasite infections.

Authors:  Alexis Kaushansky; Sebastian A Mikolajczak; Marissa Vignali; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2014-03-06       Impact factor: 3.715

6.  Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells.

Authors:  Melissa R van Dijk; Bruno Douradinha; Blandine Franke-Fayard; Volker Heussler; Maaike W van Dooren; Ben van Schaijk; Geert-Jan van Gemert; Robert W Sauerwein; Maria M Mota; Andrew P Waters; Chris J Janse
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

Review 7.  Plasmodium sporozoite-host interactions from the dermis to the hepatocyte.

Authors:  Ijeoma Ejigiri; Photini Sinnis
Journal:  Curr Opin Microbiol       Date:  2009-07-14       Impact factor: 7.934

8.  Apoptosis induced by parasitic diseases.

Authors:  Anne-Lise Bienvenu; Elena Gonzalez-Rey; Stephane Picot
Journal:  Parasit Vectors       Date:  2010-11-17       Impact factor: 3.876

9.  Suppression of host p53 is critical for Plasmodium liver-stage infection.

Authors:  Alexis Kaushansky; Albert S Ye; Laura S Austin; Sebastian A Mikolajczak; Ashley M Vaughan; Nelly Camargo; Peter G Metzger; Alyse N Douglass; Gavin MacBeath; Stefan H I Kappe
Journal:  Cell Rep       Date:  2013-03-07       Impact factor: 9.423

10.  Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events.

Authors:  Sónia S Albuquerque; Céline Carret; Ana Rita Grosso; Alice S Tarun; Xinxia Peng; Stefan H I Kappe; Miguel Prudêncio; Maria M Mota
Journal:  BMC Genomics       Date:  2009-06-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.